CohBar, Inc.
CohBar, Inc. (CWBR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CWBR · as of Jun 9, 2026
Key Statistics
Explore CohBar, Inc. Data
cwbr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 100.0%
Competitors & Peers
cwbr competitorsCWBR
BLCM
CYTO
HTGMQ
IMPL
NBSEStock Performance
Full HistoryAbout CohBar, Inc.
CohBar, Inc. CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Thei…
what is cohbar, inc. · cwbr stock overview · cohbar, inc. company profile · who is cohbar, inc. ceo · cwbr NASDAQ · cohbar, inc. headquarters · cohbar, inc. business segments
About Stock Overview & Key Data
CohBar, Inc. (CWBR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 15, 2017. As of the latest trading session, CWBR stock price is $0.41, with a market capitalization of $1.2M. The stock has returned -53.38% over the past 12 months and +0.00% year-to-date.
According to 5 Wall Street analysts, the consensus rating for CohBar, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, CohBar, Inc. reported revenue of — and net income of -$12.0M. For detailed data — including CohBar, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CohBar, Inc. (CWBR) stock price is $0.41. The stock is traded on NASDAQ under the ticker symbol CWBR. The 52-week range is $0.00 – $1.01.